Related Experiment Video
Updated: May 26, 2026

10:08
Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies
Published on: July 20, 2022
Isolation of synaptic terminals from Alzheimer's disease cortex
Sophie Sokolow1, Kristen M Henkins, Iris A Williams
1UCLA School of Nursing, Los Angeles, California 90095, USA. ssokolow@sonnet.ucla.edu
Summary
Researchers developed a new method to isolate amyloid beta (Aβ) and phosphorylated tau (p-tau) aggregates within Alzheimer's disease (AD) synapses. This technique helps understand the specific toxic species driving synaptic dysfunction in AD.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Amyloid beta (Aβ) oligomers and phosphorylated tau (p-tau) are implicated in Alzheimer's disease (AD) pathogenesis.
- The precise Aβ and p-tau species causing synaptic dysfunction in AD remain incompletely understood.
- Understanding pathology within synapses is crucial for developing effective AD therapies.
Purpose of the Study:
- To develop and validate a method for isolating synaptosomes based on size and Aβ positivity.
- To characterize the Aβ and p-tau species within isolated AD synaptosomes.
- To confirm the co-localization of Aβ and p-tau within individual synaptic terminals.
Main Methods:
- Utilized high-speed cell sorting to purify synaptosomes based on size (0.5–1.5 microns).
- Employed fluorescence-activated sorting to isolate Aβ-positive synaptosomes.
- Analyzed sorted synaptosomes using electron microscopy and immunoblotting techniques.
Main Results:
- Size-gated synaptosomes exhibited homogenous morphology consistent with synaptic vesicles.
- Sorted Aβ-positive synaptosomes showed enrichment of amyloid precursor protein (APP) and Aβ oligomers/aggregates.
- A striking accumulation of p-tau aggregates was observed in Aβ-positive synaptosomes compared to controls.
Conclusions:
- Co-localization of Aβ and p-tau within individual synaptic terminals is confirmed.
- Flow sorting of synaptosomes is a viable method for studying synaptic pathology in AD.
- This technique provides a novel approach to investigate the molecular mechanisms of synaptic failure in neurodegenerative diseases.

